SynthesisBMC musculoskeletal disorders2026
Machine learning-based risk predictive model for postoperative refractures in patients with osteoporotic vertebral compression fractures: a systematic review and critical appraisal.
Synthesis in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Artificial intelligence, explainable deep learning, and generative models for osteoporosis and bone disease prediction: a systematic review and future research roadmap.Frontiers in artificial intelligence · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo systematically evaluate the application of machine learning (ML)-based predictive models in assessing the risk of refractures following vertebral augmentation (VA) in patients with osteoporotic vertebral compression fractures (OVCFs). The methodology and performance of these models will be assessed, and key predictors will be identified. This will provide a reference for constructing high-quality predictive models in the future.
methodsA systematic search was conducted to identify relevant studies using eight electronic databases for the time period from database inception to February 28, 2026. Two reviewers independently conducted literature searches, screening, and data extraction. Eligible studies include all retrospective or prospective studies of ML models that have been developed or validated in patients with OVCFs and that predict refracture after VA. Model bias and applicability were evaluated using the Predictive Model Risk of Bias Assessment Tool (PROBAST). The quality of transparent reporting was assessed using the Multivariate Predictive Models for Individual Prognosis or Diagnosis-Artificial Intelligence (TRIPOD + AI).
resultsA total of 14 studies were included, involving 73 postoperative refractures prediction models for patients with OVCFs, constructed using 25 ML algorithms. The incidence of refractures ranged from 10.6% to 64.4%. The high-frequency predictors network diagram showed that 13 appeared at least twice and more, with age, body mass index, and radiomics features being the most common predictors. Methodological appraisal using PROBAST revealed that all 14 studies exhibited a high risk of bias (ROB). The primary risks of bias were identified as follows: a retrospective study design, a small sample size, the failure to report missing data handling methods, inappropriate variable selection methods, and a lack of external validation. The compliance of the included studies with each item on the TRIPOD + AI checklist also needs to be improved. The aspects where the quality of reports is generally insufficient include: missing sample size calculation, opaque processing of missing data, failure to provide a complete model, absence of research-related protocols and registration information, and lack of clinical application considerations. DISCUSSION: Our results indicated that most published predictive modelling studies exhibited robust predictive performance, but they still demonstrated methodological shortcomings and a high ROB. Research on predictive models for postoperative refractures risk in patients with OVCFs undergoing VA is still in its developmental stage. Future studies should adhere strictly to predictive model reporting standards and enhance validation processes to enable more effective clinical application.
trial registrationThis study is registered with PROSPERO (Registration ID: CRD 420251082219).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.